IRCT20200404046937N4已完成2 期
Evaluating the efficacy and safety of Ivermectin in the treatment of COVID-19 patients: A double-blind randomized controlled trial, phase II
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age =18 years
- •Laboratory polymerase chain reaction (PCR) confirmed infection with COVID19
- •Hospitalized
- •Satisfaction to participate in the study
- •Acceptance of non-participation in another study before the 28th day of the study
排除标准
- •Patients with a history of allergic reaction to Ivermectin
- •Renal dysfunction
- •Liver dysfunction
- •Pregnancy or deciding to get pregnant or breastfeeding
研究者
相似试验
已完成
1 期
Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adultsMalariaPACTR201908520097051Centre de Recherches Medicales de Lambarene49
招募中
3 期
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375
招募中
3 期
Effect of Ivermectin in treatment of COVID-19COVID-19 disease.COVID-19, virus not identifiedU07.2IRCT20200506047323N6Bandare-abbas University of Medical Sciences120
招募中
不适用
Efficacy of Ivermectin in the treatment of COVID-19IRCT20210901052358N4Shahid Beheshti University of Medical Sciences60
尚未招募
不适用
â??To study the effectiveness of Ivermectin with standard of care treatmentversus standard of care treatment for COVID 19 cases. A Pilot StudyCTRI/2020/04/024858Max Super Speciality Hospital A Unit of Devki Devi Foundation